Literature DB >> 56310

Dissociation of anticomplementary and adjuvant properties of proteins derived from cobra venom.

D C Morrison, J A Louis, W O Weigle.   

Abstract

The ability of preparations of cobra factor (CoF) to convert C3 via the properdin pathway (anticomplementary activity) has been demonstrated to be unrelated to its ascribed ability to convert a tolerogenic signal into an immunogenic stimulus (adjuvant activity). It has been shown that CoF preparations which have become inactive with regard to anticomplementary activity still retain full adjuvant properties. Further, when both activities are present in preparations of CoF, they can be separated by gel filtration chromatography into a fraction with approximate molecular weight 150,000 which contains anticomplementary activity and a fraction with approximate molecular weight 20,000, which contains adjuvant properties.

Mesh:

Substances:

Year:  1976        PMID: 56310      PMCID: PMC1445162     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  17 in total

1.  A method of trace iodination of proteins for immunologic studies.

Authors:  P J McConahey; F J Dixon
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

2.  Effect of cobra venom factor on the local GVH reaction. I. Partial characterization of a cytotoxic factor from cobra venom for rat lymphocytes.

Authors:  M Ballow; N K Day; R A Good
Journal:  J Immunol       Date:  1973-02       Impact factor: 5.422

3.  Complement-independence of tolerance induction.

Authors:  M B Pepys; M J Taussig
Journal:  Eur J Immunol       Date:  1974-05       Impact factor: 5.532

4.  Hypothesis. Bound C3 as the second signal for B-cell activation.

Authors:  P Dukor; K U Hartmann
Journal:  Cell Immunol       Date:  1973-06       Impact factor: 4.868

5.  Depletion of plasma complement in vivo by a protein of cobra venom: its effect on various immunologic reactions.

Authors:  C G Cochrane; H J Müller-Eberhard; B S Aikin
Journal:  J Immunol       Date:  1970-07       Impact factor: 5.422

6.  On the nature of immunological tolerance.

Authors:  M M Azar; E J Yunis; P J Pickering; R A Good
Journal:  Lancet       Date:  1968-06-15       Impact factor: 79.321

7.  A modification of the hemolytic plaque assay for use with protein antigens.

Authors:  E S Golub; R I Mishell; W O Weigle; R W Dutton
Journal:  J Immunol       Date:  1968-01       Impact factor: 5.422

8.  The failure to show a necessary role for C3 in the in vitro antibody response.

Authors:  H Waldmann; P J Lachmann
Journal:  Eur J Immunol       Date:  1975-03       Impact factor: 5.532

9.  Role of complement in induction of antibody production in vivo. Effect of cobra factor and other C3-reactive agents on thymus-dependent and thymus-independent antibody responses.

Authors:  M B Pepys
Journal:  J Exp Med       Date:  1974-07-01       Impact factor: 14.307

10.  The ability of bacterial lipopolysaccharide to modulate the induction of unresponsiveness to a state of immunity. Cellular parameters.

Authors:  J A Louis; J M Chiller; W O Weigle
Journal:  J Exp Med       Date:  1973-12-01       Impact factor: 14.307

View more
  6 in total

1.  Cell-mediated immunological responsiveness in mice decomplemented with cobra venom factor.

Authors:  V M Rumjanek; L Brent; M B Pepys
Journal:  Immunology       Date:  1978-06       Impact factor: 7.397

2.  Differential effects of pharmacologic agents on the reverse passive Arthus reaction in guinea pigs.

Authors:  Z E Mielens; J C Bhandari; T A Barbolt; V J Stecher
Journal:  Agents Actions       Date:  1984-10

3.  Plasma lipoprotein induction and suppression of the generation of cellular procoagulant activity in vitro: two procoagulant activities are produced by peripheral blood mononuclear cells.

Authors:  B S Schwartz; G A Levy; L K Curtiss; D S Fair; T S Edgington
Journal:  J Clin Invest       Date:  1981-06       Impact factor: 14.808

4.  Plasma lipoprotein induction and suppression of the generation of cellular procoagulant activity in vitro.

Authors:  G A Levy; B S Schwartz; L K Curtiss; T S Edgington
Journal:  J Clin Invest       Date:  1981-06       Impact factor: 14.808

5.  Delayed hypersensitivity reactions to Listeria monocytogenes in rats decomplemented with cobra factor and in C5-deficient mice.

Authors:  T W Jungi; M B Pepys
Journal:  Immunology       Date:  1981-06       Impact factor: 7.397

6.  Murine lymphoid procoagulant activity induced by bacterial lipopolysaccharide and immune complexes is a monocyte prothrombinase.

Authors:  B S Schwartz; G A Levy; D S Fair; T S Edgington
Journal:  J Exp Med       Date:  1982-05-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.